
WSH Care Awards 2025
Three BMAC companies were proud recipients of the WSH CARE Award, a prestigious recognition presented by the Ministry of Manpower (MOM) and the Workplace Safety
BMAC – Biopharmaceutical Manufacturer's Advisory Council
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
Site Heads / General Managers / Vice Presidents from 24 Sites across the BMAC Community came together to sign the BMAC Vision Zero Pledge on 11th Feb 2026 during its 91st BMAC Quarterly Meeting. BMAC welcomed an additional three members to the community namely Astra Zeneca, WuXi Biologics and WuXi XDC.
We, the members of the Biopharmaceutical Manufacturers’ Advisory Council in Singapore, pledge our unwavering commitment to ensuring that every employee and business partner return home safe, healthy and well both physically and mentally. At the same time, we dedicate ourselves to protecting and sustaining the environment for future generations. To achieve this, we will:
Build robust and comprehensive solutions to proactively achieve the highest possible standard of workplace safety and health, and environmental protection;
Manage a comprehensive environmental and safety compliance system that integrates health and well-being into our daily operations beyond basic regulatory requirement;
Advocate a collaborative mindset among the BMAC community to facilitate the sharing of best practices, innovations and new technologies that advance safety, health, mental wellness and environmental stewardship; and
Cultivate a safety and sustainability culture in our organizations and among our business partners, encouraging collective ownership of safety, health and environment.

Three BMAC companies were proud recipients of the WSH CARE Award, a prestigious recognition presented by the Ministry of Manpower (MOM) and the Workplace Safety

The Singapore Eye Research Institute (SERI) and Santen Pharmaceutical Co., Ltd., a global pharmaceutical company committed to eye health headquartered in Osaka, Japan have launched

Global pharma companies are looking to Asia for innovation as they consider what’s next to bolster their pipelines, including sourcing of “Best-in-Class” and “First-in-Class” assets